Delta-8 THC products provide all the benefits of delta-9 THC but with fewer adverse effects, according to consumers.
Researchers from the University of Waterloo, Ontario, report that the mean price of dried flower from legal sources fell in 2019 and then again in 2020.
After commercial edibles became legally available in 2019, cannabis-related exposures were seen to be responsible for nearly 10 percent of all ED visits for poisonings in Ontario.
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
The year posed many challenges, but cannabis businesses, research centers, and reform groups still managed to make impressive headway. Analytical Cannabis looks back on the stories and issues that dominated the cannabis industry in 2021.
Kimberly Ross of Peak Compliance Labs outlines the many obstacles hemp faces before it becomes fully regulated in the US.
The recommendations have largely been welcomed by many in the UK’s CBD industry.
Pfizer is set to acquire Arena Pharmaceuticals, a San Diego-based company currently developing a cannabinoid therapeutic called Olorinab.